title: Biological and clinical implications of HBV infection in peripheral blood mononuclear cells.
abstract: The liver is the main site of HBV replication, however extrahepatic organs, such as the lymphoid system, are an important reservoir of the virus. Viral DNA into different mononuclear cell subsets has been mainly detected in monocytes and B lymphocytes. The attachment site of the virus has been identified in the preS1 encoded protein of the virus envelope, the same involved in hepatocyte infection. The risk of HBV transmission by infected lymphocytes has been clearly documented in the setting of liver transplantation where de novo HBV infection has been found in up to about 80% of liver grafts from HBsAg negative but anti-HBc positive donors. In the hemodialysis setting the percentage of HBV DNA detection in mononuclear cells of HBsAg negative patients has been described in up to 54% of the cases. Vertical transmission studies indicate that HBV-infected mononuclear cells of the mother may result in viral infection of mononuclear cells of the newborns and possible HBV vaccine response failure. HBV can also infect bone marrow cells and in vitro studies demonstrate a block of hematopoiesis by HBV, supporting clinical observations of isolate cases of aplastic anemia associated to the infection.
authors.affiliation: Clinica Medica 5, Department of Clinical and Experimental Medicine, University of Padua, Italy. patrizia@unipd.it
authors.forename: Patrizia
authors.initials: P
authors.lastname: Pontisso
authors.forename: Laura
authors.initials: L
authors.lastname: Vidalino
authors.forename: Santina
authors.initials: S
authors.lastname: Quarta
authors.forename: Angelo
authors.initials: A
authors.lastname: Gatta
mesh_terms: D000818:Animals; D001402:B-Lymphocytes / Q000378:metabolism / Q000821:virology; D005260:Female; D006509:Hepatitis B / Q000276:immunology* / Q000628:therapy; D006514:Hepatitis B Surface Antigens / Q000378:metabolism*; D017325:Hepatitis B Vaccines; D006515:Hepatitis B virus / Q000276:immunology* / Q000472:pathogenicity; D019694:Hepatitis B, Chronic / Q000276:immunology* / Q000628:therapy; D022781:Hepatocytes / Q000378:metabolism / Q000821:virology; D006801:Humans; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control; D007963:Leukocytes, Mononuclear / Q000473:pathology / Q000821:virology*; D008099:Liver / Q000821:virology; D011247:Pregnancy; D011498:Protein Precursors / Q000378:metabolism*; D014779:Virus Replication
chemical_list: D006514:Hepatitis B Surface Antigens; D017325:Hepatitis B Vaccines; D011498:Protein Precursors; C050806:presurface protein 1, hepatitis B surface antigen